Activity of 129 Single-Agent Drugs in 228 Phase I and II Clinical Trials in Multiple Myeloma

BACKGROUND: More than 400 preclinical studies report ≥ 1 compound as cytotoxic to multiple myeloma (MM) cells; however, few of these agents became relevant in the clinic. Thus, the utility of such assays in predicting future clinical value is debatable. PATIENTS AND METHODS: We examined the applicat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kortuem, K. Martin, Zidich, Kaitlyn, Schuster, Steven R., Khan, Meaghan L., Jimenez-Zepeda, Victor H., Mikhael, Joseph R., Fonseca, Rafael, Stewart, A. Keith
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4092053/
https://ncbi.nlm.nih.gov/pubmed/24565465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2013.12.015
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia